HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yukihiko Kawasaki Selected Research

Erythema elevatum diutinum

1/2013Henoch-Schönlein purpura nephritis in childhood: pathogenesis, prognostic factors and treatment.
12/2011Mechanism of onset and exacerbation of chronic glomerulonephritis and its treatment.
10/2011Successful therapy with tonsillectomy for severe ISKDC grade VI Henoch-Schönlein purpura nephritis and persistent nephrotic syndrome.
10/2011The pathogenesis and treatment of pediatric Henoch-Schönlein purpura nephritis.
6/2010A case of Henoch-Schoenlein purpura nephritis recurring after 3 years remission.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yukihiko Kawasaki Research Topics

Disease

17Proteinuria
05/2018 - 05/2005
16Nephritis
10/2019 - 04/2003
13IGA Glomerulonephritis (IGA Nephropathy)
06/2022 - 01/2004
13Nephrotic Syndrome (Syndrome, Nephrotic)
05/2018 - 12/2002
12Infections
04/2022 - 05/2002
12Hematuria
08/2018 - 01/2004
12Glomerulonephritis
10/2016 - 07/2004
10Human Influenza (Influenza)
01/2018 - 05/2002
10Purpura
01/2013 - 08/2004
7Hemolytic-Uremic Syndrome
01/2022 - 08/2004
7Respiratory Syncytial Virus Infections
06/2011 - 05/2002
5Hypertension (High Blood Pressure)
01/2015 - 12/2008
5Erythema elevatum diutinum
01/2013 - 06/2010
4Inflammation (Inflammations)
06/2022 - 10/2005
4Subacute Sclerosing Panencephalitis (SSPE)
08/2020 - 04/2013
4Obesity
06/2020 - 01/2014
4Brain Diseases (Brain Disorder)
02/2013 - 05/2005
3Gastroenteritis
07/2021 - 02/2008
3Neoplasms (Cancer)
03/2021 - 10/2005
3Body Weight (Weight, Body)
06/2020 - 03/2015
3Disseminated Intravascular Coagulation
04/2020 - 10/2013
3Disease Progression
12/2019 - 02/2013
3Chronic Kidney Failure (Chronic Renal Failure)
12/2018 - 12/2008
3Fever (Fevers)
05/2018 - 05/2002
3Liver Diseases (Liver Disease)
04/2017 - 01/2014
3Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
01/2016 - 03/2005
3Hyperlipidemias (Hyperlipidemia)
01/2015 - 06/2007
3Systemic Lupus Erythematosus (Libman-Sacks Disease)
03/2012 - 01/2005
3IgA Vasculitis (Purpura, Schoenlein Henoch)
04/2011 - 03/2007
3Respiratory Tract Infections (Respiratory Tract Infection)
01/2011 - 02/2007
2Edema (Dropsy)
04/2020 - 06/2008
2Thrombocytopenia (Thrombopenia)
12/2019 - 10/2013
2Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
12/2019 - 01/2018
2Leukocytosis (Pleocytosis)
08/2019 - 05/2002
2Polycythemia (Erythrocytosis)
03/2017 - 12/2014
2Lipoid Nephrosis (Glomerulonephritis, Minimal Change)
10/2016 - 06/2013
2Tonsillitis
06/2016 - 11/2006
2Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
03/2016 - 08/2007
2Sclerosis
01/2016 - 05/2009
2Hyperuricemia
01/2015 - 01/2014
2Vasculitis (Vasculitides)
11/2014 - 03/2007
2Common Cold
01/2011 - 06/2010
2Bronchiolitis
01/2011 - 12/2009
2Heart Diseases (Heart Disease)
01/2011 - 12/2009
2Lung Injury
01/2011 - 12/2009

Drug/Important Bio-Agent (IBA)

16Immunoglobulin A (IgA)IBA
10/2019 - 01/2004
15Proteins (Proteins, Gene)FDA Link
01/2021 - 03/2005
13SteroidsIBA
01/2021 - 12/2002
12MethylprednisoloneFDA LinkGeneric
06/2022 - 04/2003
11Prednisolone (Predate)FDA LinkGeneric
06/2022 - 01/2004
11mizoribineIBA
06/2016 - 01/2004
9Cyclosporine (Ciclosporin)FDA LinkGeneric
05/2018 - 01/2005
8CreatinineIBA
12/2019 - 03/2005
8CytokinesIBA
01/2018 - 05/2002
8Antigen-Antibody Complex (Immune Complex)IBA
01/2016 - 03/2006
6Drug CombinationsIBA
02/2018 - 10/2011
6Pharmaceutical PreparationsIBA
06/2016 - 10/2006
5Anti-Bacterial Agents (Antibiotics)IBA
05/2018 - 11/2003
5InterleukinsIBA
01/2018 - 10/2005
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2015 - 05/2002
5Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
01/2013 - 04/2003
4EnzymesIBA
06/2022 - 04/2004
4Complement System Proteins (Complement)IBA
06/2022 - 12/2005
4Interleukin-6 (Interleukin 6)IBA
01/2022 - 05/2002
4AntibodiesIBA
08/2020 - 09/2003
4Antiviral Agents (Antivirals)IBA
01/2019 - 09/2009
4Warfarin (Coumadin)FDA LinkGeneric
06/2016 - 11/2004
4Neuraminidase (Sialidase)IBA
12/2015 - 07/2014
4Oseltamivir (Tamiflu)FDA Link
07/2015 - 11/2003
3Immunosuppressive Agents (Immunosuppressants)IBA
06/2022 - 03/2007
3Immunoglobulin E (IgE)IBA
04/2022 - 09/2003
3AntigensIBA
04/2022 - 04/2004
3oxidized low density lipoproteinIBA
01/2022 - 06/2007
3Shiga Toxin (Shigella Toxin)IBA
01/2022 - 06/2015
3VaccinesIBA
07/2021 - 02/2011
3Immunoglobulin G (IgG)IBA
08/2020 - 07/2004
3Biomarkers (Surrogate Marker)IBA
01/2020 - 12/2009
3InterferonsIBA
01/2019 - 12/2015
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2015 - 01/2012
3Zanamivir (Relenza)FDA Link
12/2015 - 07/2014
3ChemokinesIBA
12/2015 - 06/2006
2LipopolysaccharidesIBA
01/2022 - 12/2019
2Dacarbazine (DIC)FDA LinkGeneric
04/2020 - 10/2013
2Oxygen (Dioxygen)IBA
01/2020 - 04/2004
2C-Reactive ProteinIBA
08/2019 - 05/2002
2Intravenous Immunoglobulins (IVIG)FDA Link
05/2018 - 03/2012
2Rituximab (Mabthera)FDA Link
05/2018 - 03/2016
2peramivirIBA
01/2018 - 03/2015
2Thymidine Monophosphate (TMP)IBA
01/2017 - 06/2016
2DilazepIBA
06/2016 - 12/2010
2ThrombomodulinIBA
06/2015 - 10/2013
2Glucose (Dextrose)FDA LinkGeneric
01/2015 - 01/2014

Therapy/Procedure

38Therapeutics
06/2022 - 04/2003
8Tonsillectomy
06/2022 - 11/2006
5Plasmapheresis
01/2013 - 08/2004
3Nuclear Power Plants
09/2020 - 12/2014
3Aftercare (After-Treatment)
12/2018 - 11/2014
2Mechanical Ventilators (Ventilator)
04/2022 - 04/2004
2Transplantation
01/2022 - 11/2021
2Hematopoietic Stem Cell Transplantation
01/2022 - 04/2016